ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Torque Teno Virus – Inverse Association with Late Silent Antibody Mediated Kidney Allograft Rejection.

G. Bond,1 M. Schiemann,1 F. Eskandary,1 H. Herkner,2 E. Puchhammer,3 R. Oberbauer,1 G. Böhmig.1

1Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria
2Emergency Medicine, Medical University of Vienna, Vienna, Austria
3Virology, Medical University of Vienna, Vienna, Austria.

Meeting: 2016 American Transplant Congress

Abstract number: A225

Keywords: Alloantibodies, Graft failure, Kidney transplantation, Reinfection

Session Information

Session Name: Poster Session A: Long Term Outcomes in Kidney Transplantation

Session Type: Poster Session

Date: Saturday, June 11, 2016

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Halls C&D

Clinical Problem and hypothesis: Antibody mediated rejection (ABMR) is a cardinal cause of late graft failure after kidney transplantation (KTX). A promising predictive diagnostic tool is the quantification of the plasma load of the apathogenic Torque Teno virus (TTV) which might mirror the level of immunosuppression and thus reflect the risk of rejection.

Methods: In this prospective study (cross-sectional screening after a median of 6.3 years post-transplantation in the context of an ongoing interventional trial, NCT01873157) 715 adult patients with a functioning kidney allograft >6 months post-transplantation (eGFR >20mL/min/1.73m2) were subjected to RT-PCR based TTV quantification and bead array-based screening for anti-HLA donor specific antibodies (DSA). DSA positive patients were subjected to protocol biopsies.

Results: TTV (>2log10 copies/mL) was detected in 678 of the 715 patients (95%) with a median of 2.3×105 (IQR 1.9×104-1.9×106). TTV load was highest in the first year after transplantation with a median of 3.4×106 (IQR 1.4×105-8.7×107; P<0.001). TTV load was higher after induction therapy (P<0.001) and in patients on tacrolimus-based immunosuppression (P=0.002). Among the 86 DSA+ recipients, 46 patients (53%) were diagnosed with ABMR according to the Banff 2013 scheme. ABMR+ patients had significantly lower TTV loads (median, IQR; 6.6×104, [IQR 3.0×103-7.2×105]) than patients without ABMR (N=669; 2.6×105, [IQR 2.2×104-2.1×106]; P=0.003; risk ratio for TTVlog, 0.91, 95% confidence interval [CI], 0.87 to 0.96; P=0.001). Bivariate analysis revealed a robust and linear inverse association of TTV with the diagnosis of ABMR independently of time of screening and other predictors of ABMR. Adjusted risk ratio for TTVlog in a multivariate model was 0.94 (95% CI 0.90 to 0.99; P=0.016). Similar results were obtained in a subgroup analysis restricted to the 86 patients subjected to a protocol biopsy, where TTV load in ABMR- patients was higher compared to ABMR+ patients (N=40; 4.5×105, [IQR 4.3×104– 3.9×106]; P=0.001).

Conclusion and outlook: Our results demonstrate a lower TTV load in KTX patients with ABMR. Monitoring of TTV load could represent a useful novel tool for early therapeutic intervention to prevent late ABMR and graft loss.

CITATION INFORMATION: Bond G, Schiemann M, Eskandary F, Herkner H, Puchhammer E, Oberbauer R, Böhmig G. Torque Teno Virus – Inverse Association with Late Silent Antibody Mediated Kidney Allograft Rejection. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Bond G, Schiemann M, Eskandary F, Herkner H, Puchhammer E, Oberbauer R, Böhmig G. Torque Teno Virus – Inverse Association with Late Silent Antibody Mediated Kidney Allograft Rejection. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/torque-teno-virus-inverse-association-with-late-silent-antibody-mediated-kidney-allograft-rejection/. Accessed May 9, 2025.

« Back to 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences